Recompensation after transjugular intrahepatic portosystemic shunt reduces mortality risk: A long-term follow-up study

Cirrhosis is a chronic progressive liver disease characterized by the replacement of normal liver architecture with fibrous tissue and regenerative nodules, leading to gradual loss of liver function and potentially triggering a range of serious complications [1,2]. The progression of cirrhosis can be divided into compensated and decompensated stages [3,4]. Traditionally, decompensation was considered an irreversible stage of the disease. However, recent studies have shown that decompensated cirr…

Read the full article on ejradiology.com